These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7828276)

  • 21. cis-diamminedichloroplatinum(II)-resistant sublines derived from two human ovarian tumor cell lines.
    Kuppen PJ; Schuitemaker H; van 't Veer LJ; de Bruijn EA; van Oosterom AT; Schrier PI
    Cancer Res; 1988 Jun; 48(12):3355-9. PubMed ID: 2897238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined antitumor effects of bee venom and cisplatin on human cervical and laryngeal carcinoma cells and their drug resistant sublines.
    Gajski G; Čimbora-Zovko T; Rak S; Rožman M; Osmak M; Garaj-Vrhovac V
    J Appl Toxicol; 2014 Dec; 34(12):1332-41. PubMed ID: 25493319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. cis-Diamminedichloroplatinum(II) resistant human tumor cell lines are collaterally sensitive to PtCl4(Rh-123)2: evidence for mitochondrial involvement.
    Ara G; Kusumoto T; Korbut TT; Cullere-Luengo F; Teicher BA
    Cancer Res; 1994 Mar; 54(6):1497-502. PubMed ID: 8137254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. alpha(v)beta(3) Integrin-mediated drug resistance in human laryngeal carcinoma cells is caused by glutathione-dependent elimination of drug-induced reactive oxidative species.
    Brozovic A; Majhen D; Roje V; Mikac N; Jakopec S; Fritz G; Osmak M; Ambriovic-Ristov A
    Mol Pharmacol; 2008 Jul; 74(1):298-306. PubMed ID: 18441044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Collateral methotrexate resistance in cultured human head and neck carcinoma cells selected for resistance to cis-diamminedichloroplatinum(II).
    Rosowsky A; Wright JE; Cucchi CA; Flatow JL; Trites DH; Teicher BA; Frei E
    Cancer Res; 1987 Nov; 47(22):5913-8. PubMed ID: 3664492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance of human cervical carcinoma cells to tumor necrosis factor correlates with their increased sensitivity to cisplatin: evidence of a role for DNA repair and epidermal growth factor receptor.
    Nishikawa K; Rosenblum MG; Newman RA; Pandita TK; Hittelman WN; Donato NJ
    Cancer Res; 1992 Sep; 52(17):4758-65. PubMed ID: 1380890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin.
    Kasahara K; Fujiwara Y; Nishio K; Ohmori T; Sugimoto Y; Komiya K; Matsuda T; Saijo N
    Cancer Res; 1991 Jun; 51(12):3237-42. PubMed ID: 1645616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circumvention of ara-C resistance by aphidicolin in blast cells from patients with AML.
    Sargent JM; Elgie AW; Williamson CJ; Lewandowicz GM; Taylor CG
    Br J Cancer; 2001 Mar; 84(5):680-5. PubMed ID: 11237390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment of cisplatin-resistant variants of human neuroblastoma cell lines, TGW and GOTO, and their drug cross-resistance profiles.
    Iwasaki I; Sugiyama H; Kanazawa S; Hemmi H
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):438-44. PubMed ID: 12107547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of resistance mechanisms to cis-diamminedichloroplatinum(II) in three sublines of the CC531 colon adenocarcinoma cell line in vitro.
    Oldenburg J; Begg AC; van Vugt MJ; Ruevekamp M; Schornagel JH; Pinedo HM; Los G
    Cancer Res; 1994 Jan; 54(2):487-93. PubMed ID: 8275486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Up-regulation of human chorionic gonadotropin alpha subunit gene and human mitochondrial cytochrome c oxidase subunit II gene in cis-Diamminedichloroplatinum(II)-resistant human head and neck squamous carcinoma cells].
    Higuchi E
    Hokkaido Igaku Zasshi; 1999 May; 74(3):231-8. PubMed ID: 10422566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Modulation of cisplatin cytotoxicity by amphotericin B in six human cell lines of medullary thyroid cancer].
    Massart C; Gibassier J; Le Gall F; Raoul ML; Leclech G; Lucas C
    Bull Cancer; 1996 Aug; 83(8):619-25. PubMed ID: 8869041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells.
    Lai SL; Hwang J; Perng RP; Whang-Peng J
    Oncol Res; 1995; 7(1):31-8. PubMed ID: 7549042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nucleotide excision repair in the human ovarian carcinoma cell line (2008) and its cisplatin-resistant variant (C13*).
    Moorehead RA; Armstrong SG; Rainbow AJ; Singh G
    Cancer Chemother Pharmacol; 1996; 38(3):245-53. PubMed ID: 8646799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased adenoviral transduction efficacy in human laryngeal carcinoma cells resistant to cisplatin is associated with increased expression of integrin alphavbeta3 and coxsackie adenovirus receptor.
    Ambriović-Ristov A; Gabrilovac J; Cimbora-Zovko T; Osmak M
    Int J Cancer; 2004 Jul; 110(5):660-7. PubMed ID: 15146554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diazenes as modificators of drug-resistance in tumor cells.
    Osmak M; Bordukalo T; Ristov AA; Jernej B; Kosmrlj J; Polanc S
    Neoplasma; 2000; 47(6):390-5. PubMed ID: 11263864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antisense cyclin D1 enhances sensitivity of head and neck cancer cells to cisplatin.
    Wang MB; Yip HT; Srivatsan ES
    Laryngoscope; 2001 Jun; 111(6):982-8. PubMed ID: 11404608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amphotericin B-induced sensitivity to actinomycin D in drug-resistant Hela cells.
    Medoff J; Medoff G; Goldstein MN; Schlessinger D; Kobayaski GS
    Cancer Res; 1975 Sep; 35(9):2548-52. PubMed ID: 1149049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum(II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibody.
    Mizutani Y; Bonavida B; Koishihara Y; Akamatsu K; Ohsugi Y; Yoshida O
    Cancer Res; 1995 Feb; 55(3):590-6. PubMed ID: 7834629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitivity to novel platinum compounds of panels of human lung cancer cell lines with acquired and inherent resistance to cisplatin.
    Twentyman PR; Wright KA; Mistry P; Kelland LR; Murrer BA
    Cancer Res; 1992 Oct; 52(20):5674-80. PubMed ID: 1327513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.